George A. Nankervis

985 total citations
30 papers, 649 citations indexed

About

George A. Nankervis is a scholar working on Epidemiology, Infectious Diseases and Physiology. According to data from OpenAlex, George A. Nankervis has authored 30 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Physiology. Recurrent topics in George A. Nankervis's work include Cytomegalovirus and herpesvirus research (14 papers), Virology and Viral Diseases (5 papers) and Herpesvirus Infections and Treatments (4 papers). George A. Nankervis is often cited by papers focused on Cytomegalovirus and herpesvirus research (14 papers), Virology and Viral Diseases (5 papers) and Herpesvirus Infections and Treatments (4 papers). George A. Nankervis collaborates with scholars based in United States, Greece and Barbados. George A. Nankervis's co-authors include Mary L. Kumar, Eli Gold, William Berenberg, Claire B. Ernhart, Irwin B. Jacobs, Ashir Kumar, Frederick Cox, David L. Madden, Blaise L. Congeni and James F. Carney and has published in prestigious journals such as New England Journal of Medicine, JNCI Journal of the National Cancer Institute and PEDIATRICS.

In The Last Decade

George A. Nankervis

29 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George A. Nankervis United States 12 515 190 154 103 60 30 649
O Pettay Finland 16 730 1.4× 160 0.8× 57 0.4× 80 0.8× 66 1.1× 30 915
J. J. Roord Netherlands 15 327 0.6× 100 0.5× 79 0.5× 67 0.7× 75 1.3× 27 649
Sally A. Hensen United States 15 394 0.8× 127 0.7× 60 0.4× 259 2.5× 52 0.9× 25 706
Inge Panum Jensen Denmark 12 238 0.5× 301 1.6× 73 0.5× 217 2.1× 64 1.1× 18 648
Alfred D. Heggie United States 15 305 0.6× 131 0.7× 37 0.2× 41 0.4× 81 1.4× 36 590
A Terragna Italy 15 318 0.6× 177 0.9× 24 0.2× 120 1.2× 56 0.9× 46 676
Max B. Lurie United States 15 247 0.5× 332 1.7× 34 0.2× 164 1.6× 21 0.3× 29 687
Joseph V. Baublis United States 8 265 0.5× 123 0.6× 23 0.1× 102 1.0× 28 0.5× 11 430
Saroj Bakshi United States 17 273 0.5× 305 1.6× 31 0.2× 172 1.7× 29 0.5× 39 675
Otto F. Sieber United States 11 603 1.2× 301 1.6× 19 0.1× 151 1.5× 34 0.6× 26 853

Countries citing papers authored by George A. Nankervis

Since Specialization
Citations

This map shows the geographic impact of George A. Nankervis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Nankervis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Nankervis more than expected).

Fields of papers citing papers by George A. Nankervis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Nankervis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Nankervis. The network helps show where George A. Nankervis may publish in the future.

Co-authorship network of co-authors of George A. Nankervis

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Nankervis. A scholar is included among the top collaborators of George A. Nankervis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Nankervis. George A. Nankervis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Peter K. H., et al.. (1988). Evaluation of a prescreening blood donor program for prevention of perinatal transfusion-acquired cytomegalovirus (CMV) infection. Journal of Perinatal Medicine. 16(2). 127–131. 7 indexed citations
2.
Lau, Peter K. H., et al.. (1986). Evaluation of Cytomegalovirus (CMV) Antibody Screening Tests for Blood Donors. American Journal of Clinical Pathology. 86(4). 523–526. 11 indexed citations
3.
Nankervis, George A.. (1986). Antiviral Chemotherapy. Pediatric Annals. 15(6). 442–444. 9 indexed citations
4.
Kumar, Mary L., et al.. (1984). Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers. The Journal of Pediatrics. 104(5). 669–673. 64 indexed citations
5.
Kumar, Mary L., Eli Gold, Irwin B. Jacobs, Claire B. Ernhart, & George A. Nankervis. (1984). Primary Cytomegalovirus Infection in Adolescent Pregnancy. PEDIATRICS. 74(4). 493–500. 32 indexed citations
6.
Kumar, Ashir, David L. Madden, & George A. Nankervis. (1984). Humoral and cell-mediated immune responses to herpesvirus antigens during pregnancy—A longitudinal study. Journal of Clinical Immunology. 4(1). 12–17. 30 indexed citations
7.
Nankervis, George A., Mary L. Kumar, Frederick Cox, & Eli Gold. (1984). A prospective study of maternal cytomegalovirus infection and its effect on the fetus. American Journal of Obstetrics and Gynecology. 149(4). 435–440. 47 indexed citations
8.
Nankervis, George A., et al.. (1983). Cytomegalovirus infection. Postgraduate Medicine. 73(4). 62–69. 6 indexed citations
9.
Kumar, Ashir & George A. Nankervis. (1980). Latex agglutination test and countercurrent immunoelectrophoresis for detection of group B streptococcal antigen. The Journal of Pediatrics. 97(2). 328–329. 3 indexed citations
10.
Kumar, Ashir & George A. Nankervis. (1979). Patient compliance to antibiotic regimens. Postgraduate Medicine. 65(3). 165–167. 3 indexed citations
11.
Evans, Alfred S., et al.. (1979). A Serological Survey of St Lucia. International Journal of Epidemiology. 8(4). 327–332. 8 indexed citations
12.
Nankervis, George A., et al.. (1977). A prospective study of cytomegalovirus infections in 78 renal allograft recipients.. PubMed. 6. 8–12. 2 indexed citations
13.
Congeni, Blaise L. & George A. Nankervis. (1976). Clostridia septicum bacteremia in a patient with aplastic anemia. The Journal of Pediatrics. 89(2). 331–331. 8 indexed citations
14.
Nankervis, George A.. (1974). Bacterial Meningitis. Medical Clinics of North America. 58(3). 581–592. 8 indexed citations
15.
Carney, James F., et al.. (1974). Effect of Sera from Patients with Sarcoidosis on <i>in vitro</i> Lymphocyte Response. International Archives of Allergy and Immunology. 46(2). 183–190. 22 indexed citations
16.
Singer, Harvey S., George A. Nankervis, & Irwin A. Schafer. (1972). LEUKOCYTE BETA-GALACTOSIDASE ACTIVITY IN THE DIAGNOSIS OF GENERALIZED GM, GANGLIOSIDOSIS. PEDIATRICS. 49(3). 352–361. 11 indexed citations
17.
Lerman, Stephen J., et al.. (1971). Immunologic Response, Virus Excretion and Joint Reactions with Rubella Vaccine. Journal of Occupational and Environmental Medicine. 13(7). 361–361. 2 indexed citations
18.
Berenberg, William & George A. Nankervis. (1970). LONG-TERM FOLLOW-UP OF CYTOMEGALIC INCLUSION DISEASE OF INFANCY. PEDIATRICS. 46(3). 403–410. 66 indexed citations
20.
Nankervis, George A. & H. R. Morgan. (1959). Infection of chick cells with Rous sarcoma virus in vitro. Virology. 9(4). 708–710. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026